UK Vaccination Progress Update

The UK has set out its steps to reduce coronavirus restrictions. It’s hoped the fantastic progress of the vaccination programme will mean this is the last COVID-19 lockdown in the UK.

We’ve been told that decisions will be informed by the data, so let’s dig into the stats!

Cases – and the rate of infection

Cases have been dropping for the last seven weeks, from a high of 414k confirmed cases in Week 44 – 4th of Jan to 10th of Jan. The ONS estimated 1 in 50 people had the virus in England in the last week of 2020. That’s now dropped to 1 in 145 people.

The rate of infection (the “R” rate) has been below 1 for seven weeks now – by my estimates, which are based on the reported positive test results.

An “R” of 0.9 means every 100 people with the virus, infect a further 90. An “R” of 1.1 means those 100 people instead infect 110 people.

Cases are going in the right direction, although I’d argue it’s not cases that matter anymore.

UK COVID-19 Cases, Hospitalisations, Deaths and Vaccinations

Hospital Patients

The reason we’ve all been asked to “Stay at home” is to “Protect the NHS” and “Save lives”. The more people who get ill with coronavirus, the more pressure that puts on the National Health Service.

It’s okay to have COVID-19 cases if nobody goes to hospital. Thanks to the vaccine roll-out, fewer people are, and here’s a great visual tweet explaining why.

Vaccination almost completely eliminates the chance of getting severe or moderate symptoms!

There are still significant numbers of people in hospital, but it’s now less than half the peak and dropping further.

Deaths

The vaccine will reduce hospital admissions, but it’ll also reduce deaths – even more significantly so.

Even a single dose of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines is proving to have a significant impact on immunity to COVID-19. This is great news and will be contributing to the rapid fall in deaths in the UK.

In just five weeks, the UK has gone from ~8.7k coronavirus deaths a week to ~2.3k. To put that in perspective, around 3.2k people sadly die from cancer each week.

Vaccines

Here’s why the UK has been able to set-out it’s roadmap out of lockdown: the vaccine roll-out.

The UK is vaccinating the entire adult population (53 million people) meaning it needs to administer 106 million vaccinations.

So far over 1 in 3 people have had their first dose, and the programme is already over 20% complete.

UK COVID-19 Vaccine Progress

If the UK continues to roll-out vaccinations at the current rate, it’s set to meet, if not exceed its targets to re-open the country.

All the data I’ve shared in this post comes from the UK Gov Coronovirus Dashboard. Predictions are based on my interpretation of this data and vaccine supply data.

SIENNA final conference: 10 – 12 March

The SIENNA Project is holding its final (online) conference on Ethics, Human Rights & Emerging Technologies.

Various project members and a host of professors from various fields will present and discuss results and proposals for the ethical management of new and emerging technologies. The conference has four parts that can be attended separately. The programme is now available for all sessions, and they are all individually free to attend!

Here is just a little taster, all times are CET:

10 March
14:00-17:00 Human Genetics and Genomics: Ethical, legal and human rights challenges

11 March
09:30-12:30 Human Enhancement: Ethical, legal and human rights challenges
13:30-17:30 Artificial Intelligence and Robotics: Ethical, legal and human rights challenges

12 March
13:00-17:00 Governance of emerging technologies: incorporating ethics and human rights

Two panel discussions might be of particular interest to Technology Bloggers readers:

On Thursday 11 March at 11:40, future strategies for human enhancement, ethics and human rights features the following interesting array of speakers.

Lesley-Ann Daly, CyborgNest
Christopher Coenen, Karlsruhe Institute of Technology
Marc Roux, President of  the Association Française Transhumaniste – Technoprog
Yana Toom, Member of European Parliament, STOA member.

While later in the afternoon (at 16:40) a panel will discuss strategies for future ethical and human rights challenges of AI and robotics, and it also includes some really interesting names:

Cornelia Kutterer, Senior Director on Microsoft’s European Government Affairs team in Brussels
Patrick Breyer, Member of European Parliament, Group of the Greens/European Free Alliance
Clara Neppel, Senior Director of the IEEE European office
Vidushi Marda, Article 19 and Carnegie India

Have a look at the full programme, or go to the conference website landing page to register. It’s free!

A Breathalyzer that can Detect COVID-19

In the Netherlands, the Dutch health authorities are using a breathalyzer machine called the SprioNose to help detect COVID-19 cases. The machine works rather like an alcohol test in that it detects traces of the virus in the breath blown into the machine.

The health department state that in 70% of cases tested, the rapid test can determine with certainty that they are not infected with the coronavirus. For the remaining 30%, the results are not conclusive. If the breath test does not provide a definite negative result, the person will be given another test to find out if they are infected with coronavirus with the common PCR test.

The results only take a couple of minutes, and the screening capability means that many people can avoid the invasive nose swab and the related procedures for analysis, saving a few red noses and a lot of medical testing resources.

The SpiroNose technology was developed by the company Breathomix. The Leiden University Medical Centre and GGD Amsterdam (the health department) have thoroughly tested the SpiroNose at coronavirus test locations. At the moment, some 600 breath tests can take place every day in Amsterdam, but this will quickly increase to more than 2,500 breath tests per day. Moving forward, the rapid breath test will also be used in the rest of the Netherlands.

Bring it on I say!